WHO has identified four key actions countries can take to prevent viral hepatitis B and C among people who inject drugs. Of the estimated 16 million people who inject drugs worldwide, it is estimated that 10 million are infected with hepatitis C. An additional 1.2 million are infected with hepatitis B.
Following the first warning of the outbreak in Greece, the EMCDDA commissioned a rapid analysis of the situation with regard to the latest epidemiological data and prevention measures being taken.
The final report of the Global Commission on HIV and the Law presents a coherent and compelling evidence base on human rights and legal issues relating to HIV.
The Scottish Government established a national naloxone programme in 2010 aimed at reducing the increasing levels of drug-related death. This review aims to describe the journey to this landmark public health programme, detailing the reseach, advocacy and policy contributions that facilitated its creation.
In this special issue, some of the UK’s top addictions experts consider the challenges facing drug treatment in a time of increasing austerity in the public funding of drug treatment and research.
The purpose of this report is to critically examine drug treatment courts (DTCs) in Canada using the available evidence, which includes process and outcome evaluations of existing DTCs, grey literature and academic research. Our assessment is also informed by interviews with a number of key informants who interact with DTCs in various ways.
This report by Release looks at over 20 countries that have adopted some form of decriminalisation of drug possession, including some States that have only decriminalised cannabis possession.
